Nutraceutical Market in India to Reach USD 12.49 Billion by 2024

Key facts

  • Market size: US$4.4 billion in 2018, up from US$2.8 billion in 2015.
  • Forecast: about 19% growth a year to US$12.49 billion by 2024.
  • Dietary supplements were about 64% of the market, functional foods and drinks about 36%.
  • India supplied a large share of the world’s herbal extracts but only about 2% of the global nutraceutical market.
  • Estimates published in 2025 range from under US$10 billion to about US$30 billion for 2024, depending on scope.

India’s nutraceutical market was valued at US$4.4 billion in 2018, up from US$2.8 billion three years earlier. Our forecast expected growth of around 19% a year to US$12.49 billion by 2024, driven by rising chronic illness, a fast-growing fitness culture and a long tradition of herbal and Ayurvedic remedies.

India held a paradox at the time: it was one of the world’s biggest suppliers of herbal extracts and raw materials for supplements, yet it accounted for only about 2% of global nutraceutical sales.

Definition and scope

Nutraceuticals are products derived from food or herbs that are sold for a health benefit beyond basic nutrition: preventing disease, supporting a body function or improving general wellbeing. They sit between food and medicine. The market splits into:

  • Dietary supplements: vitamins and minerals, herbal extracts, protein powders and other supplements.
  • Functional foods and beverages: fortified foods, health drinks, energy drinks, probiotic products.

Market size and segments

In 2018 the market broke down as follows:

SegmentShare (%)Size 2018 (US$ bn)Expected growth a year (%)
Dietary supplements642.8119
of which vitamins and minerals40 of supplements1.13
of which herbal extracts30 of supplementsabout 0.84
of which protein supplements25 of supplementsabout 0.70
Functional foods and beverages361.5815.6

Source: Reogma forecast, 2020.

Traditional products such as chyawanprash sit alongside global brands. Amway’s Nutrilite range led the supplements market with about a third of sales, followed by Indian companies such as Dabur, Himalaya and Patanjali, food groups such as NestlĂ© India and Britannia, and Herbalife, with around 5% of supplements. Green tea extract is one of the best-known ingredients, and our report on green tea in India follows it from garden to shelf.

Growth drivers

Four forces were behind the forecast:

  1. Chronic disease. India had about 69 million people with type 2 diabetes in the late 2010s, a figure projected to approach 98 million by 2030, along with rising heart disease and cancer.
  2. Fitness. India had roughly 21,000 gyms, yoga centers and wellness centers, and the fitness industry was growing 16% to 18% a year.
  3. Ageing. People over 60 were expected to rise from about 8% of the population to more than 20% by 2050, roughly 340 million people.
  4. Awareness. Surveys showed many young consumers treating health drinks and supplements as part of daily life.

Fish oil links the market to India’s fish industry.

Ingredients such as curcumin from turmeric, omega-3 fatty acids, antioxidants, probiotics and fiber attracted particular interest, though the strength of evidence varies a great deal by product.

Risks and challenges

Quality and regulation were the industry’s weak point. Around 60% of dietary supplements on the Indian market were estimated to be unregistered or unapproved, and clear, enforced rules were still developing. Safety concerns are real: research has documented liver and kidney damage linked to some herbal products contaminated with heavy metals or other toxins, and misuse of supplements can mask or worsen medical conditions.

That cuts both ways for the industry. Poor-quality products damage trust in the whole category, while companies that can prove quality and efficacy gain an advantage. Drug-style claims bring drug-style rules, as in the global pharmaceutical industry.

What happened since

Updated November 2026

India’s nutraceutical market grew strongly, but estimates of its size now diverge sharply. CareEdge Ratings put it at about US$29 to 30 billion in 2024 and projected US$55 to 57 billion by 2030, using a broad definition. Narrower estimates are far lower: a market research firm put 2024 sales at about US$8 billion, and the head of the food regulator FSSAI cited around US$4 billion. CareEdge Ratings

The estimates side by side:

Source2024 estimate (US$ bn)Scope
Reogma forecast (2020)12.49supplements plus functional foods
CareEdge Ratings29 to 30broad, incl. fortified foods and Ayurvedic products
IMARCabout 8narrower product definition
FSSAI CEO (2024 remark)about 4regulated supplement categories

Source: as listed.

The spread shows how much depends on what’s counted: whether fortified foods, Ayurvedic products and sports nutrition are in or out. On the narrower measures, the 2020 forecast was roughly right; on the broad ones, the market is far bigger. Regulation also tightened: FSSAI introduced dedicated rules for health supplements and nutraceuticals and has stepped up enforcement against unapproved claims.

Reogma’s take

For SMEs, India is attractive both as a market and as a supply base. Contract manufacturing, herbal extraction, testing labs, packaging and direct-to-consumer brands built on e-commerce and social media have all grown quickly.

Compliance is the price of entry. Register products properly with FSSAI, keep health claims within what the rules allow, and invest in testing for contaminants. In a crowded market, verifiable quality is one of the few lasting advantages.